Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1991
11/02/1991WO1991016887A1 Biodegradable polyesters for sustained drug delivery
11/02/1991CA2081897A1 Biodegradable polyesters for sustained drug delivery
10/1991
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016330A1 Amethopterin(methotrexate) pro-drugs, intermediate products, a preparation method, and compositions containing them
10/31/1991WO1991016324A1 Novel cc-1065 analogs
10/31/1991WO1991016077A1 Improved method to administer drugs by iontophoresis
10/31/1991WO1991016072A1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/31/1991WO1991016071A1 Antibody conjugates for treatment of neoplastic disease
10/31/1991WO1991016068A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
10/31/1991WO1991016042A1 Controlled release drug formulation
10/31/1991WO1991016038A1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof
10/31/1991WO1991016024A1 Cationic lipids for intracellular delivery of biologically active molecules
10/31/1991CA2081308A1 Method for increasing blood-brain barrier permeability
10/31/1991CA2078998A1 Improved method to administer drugs by iontophoresis
10/31/1991CA2041387A1 Cosmetic or dermatopharmaceutical composition containing vesiculae formed with a phospholipidic/glycolipid mix
10/30/1991EP0454396A1 Tablet composition and method for problem pharmaceutical materials
10/30/1991EP0454383A1 Large intestinal dissociative polypeptide series oral formulation
10/30/1991EP0454287A2 Zein as a moisture barrier for sugarless edible compositions and methods for preparing same
10/30/1991EP0454127A1 Hardening agent for affected tissues of digestive system
10/30/1991EP0454089A1 Percutaneously absorbable eperisone or tolperisone preparation
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0453621A1 Polymer-modified drugs having enhanced biological and pharmacological activities
10/30/1991EP0453498A1 Method of promoting hair growth by applying a blood platelet extract
10/30/1991EP0333740B1 Pharmaceutically active conjugates having improved body tissue binding specificity
10/30/1991EP0305409B1 Solubilization of proteins for pharmaceutical compositions using polyproline conjugation
10/30/1991EP0179808B1 Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders
10/29/1991US5061700 Glyceryl acetate ointment vehicles
10/29/1991US5061486 Dithranol composition containing no oily ingredients
10/28/1991WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME
10/28/1991WO1991016869A1 Polymeric drug delivery system
10/28/1991CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same
10/28/1991CA2079676A1 Polymeric drug delivery system
10/28/1991CA2063244A1 Fucosyl transferases involved in adhesion molecule expression
10/27/1991WO1991016058A1 Composition and method for topical treatment of damaged or diseased tissue
10/27/1991WO1991016041A1 Pharmaceutical compositions
10/27/1991CA2081340A1 Composition and method for topical treatment of damaged or diseased tissue
10/27/1991CA2081109A1 Pharmaceutical compositions
10/24/1991CA2039742A1 Tablet composition and method for problem pharmaceutical materials
10/23/1991EP0453397A1 Multiple encapsulated flavor delivery system and method of preparation
10/23/1991EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
10/23/1991EP0453082A1 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
10/23/1991EP0453018A2 Poly (alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
10/23/1991EP0453001A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/23/1991EP0452995A2 Lipid-containing plastics
10/23/1991EP0452858A2 Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
10/23/1991EP0452697A1 Stabilizer for 4-ethyl-2-hydroxyimino5-nitro-3-hexenamide-containing preparation and stabilizing method therefor
10/23/1991EP0452457A1 Method of in vivo delivery of functioning foreign genes.
10/23/1991EP0452389A1 Liquid sustained release composition
10/23/1991EP0452334A1 Mucoadhesive carrier for delivery of therapeutical agent
10/23/1991EP0170697B1 Toxin conjugates
10/23/1991CN1055485A Stable primycin agueous solution, composition of pharmaceutical and protective skin agent containing same and process for their preparation
10/22/1991US5059628 Proline or prolinol ester to enhance absorption
10/22/1991US5059626 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
10/22/1991US5059594 Phytic acid compositions
10/22/1991US5059591 polyene macroloid antibiotics, anthracyclines and cisplatin bonded with ligands, such as phospholipids and sterols
10/22/1991US5059587 Physiologically active peptide composition for nasal administration
10/22/1991US5059427 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
10/22/1991US5059426 Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
10/22/1991US5059421 Preparation of targeted liposome systems of a defined size distribution
10/22/1991CA1291044C Spray dried acetaminophen
10/22/1991CA1291038C Method for preventing coloration of aqueous preparations of cefmenoxime
10/22/1991CA1291037C Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
10/22/1991CA1291036C Nasal administration of drugs
10/19/1991WO1991016057A1 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING
10/19/1991CA2080224A1 Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling
10/19/1991CA2040236A1 Poly (.alpha.-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
10/18/1991CA2040471A1 Controlled release drug formulation
10/18/1991CA2035155A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/18/1991CA2031994A1 Injectable formulations containing the sodium salt of naproxen
10/17/1991WO1991015514A1 Oxidation resistant thrombomodulin analogs
10/17/1991WO1991015509A1 Methods and formulations for stabilizing fibroblast growth factor
10/17/1991WO1991015467A1 Aminopolycarboxylic acid chelating agents
10/17/1991WO1991015260A1 Device and method for iontophoretic drug delivery
10/17/1991WO1991015250A1 Amphoteric hydrogel for medical devices
10/17/1991WO1991015244A2 Stable microbubbles suspensions injectable into living organisms
10/17/1991WO1991015242A1 Conjugate compounds of polymers with other organic molecular entities
10/17/1991WO1991015241A1 Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
10/17/1991WO1991015235A1 t-PA ENHANCER PROFILE
10/17/1991WO1991015233A1 Use of protease nexin-i to mediate wound healing
10/17/1991WO1991015215A1 Fluid resuscitation
10/17/1991WO1991015210A1 Compositions comprising cytotoxic agent and permeation enhancers
10/17/1991WO1991015202A1 Pharmaceutical aqueous solution of 4-[2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid
10/17/1991WO1991015193A1 Microspheres, a preparation method therefor and uses thereof
10/17/1991WO1991015192A1 Skin-compatible aqueous tenside mixtures
10/17/1991WO1991015176A1 Device and method for enhanced administration of physostigmine
10/17/1991DE4012514A1 Prepn. of semi-solid cpd. contg. micronised active ingredients - by stirring melt of non-ionic surfactants and higher fatty acid ester(s) to give semi-solid, then adding micronised active ingredient
10/17/1991CA2084073A1 Fluid resuscitation
10/17/1991CA2079783A1 Use of protease nexin-i to mediate wound healing
10/17/1991CA2060318A1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/17/1991CA2029857A1 Sustained-release preparation composition comprising pyridazinone compound
10/16/1991EP0452268A2 Substained release of active agents from bioadhesive microcapsules
10/16/1991EP0452202A1 Aqueous cosmetic or dermo-pharmaceutical composition containing in suspension hydrated spheroids of hydrophilic lipidic substance
10/16/1991EP0452179A2 Polymer-combined drug for gastric treatment and a method for producing the drug
10/16/1991EP0452145A2 Coated composition and its preparation process
10/16/1991EP0451972A1 Utilization of enzymes
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451810A1 Hapten-biotin-conjugates and their use
10/16/1991EP0451484A1 Deprenyl/L-dopa/carbidopa pharmaceutical composition
10/16/1991EP0451461A2 Use of mixtures of polyglycerol fatty acid esters as emulsifiers in cosmetic and pharmaceutical compositions
10/16/1991EP0451299A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
1 ... 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 ... 1712